Molecular Diagnostics Market Share - Forecast Report, 2032

Molecular Diagnostics Market - By Product (Instruments, Reagents & Kits), By Technology (Polymerase Chain Reaction, Hybridization, Sequencing, Microarrays), By Application (Infectious Disease Diagnostics), By End-use & Forecast, 2023-2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Industry coverage

1.2&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; working

1.3.1&nbsp;&nbsp;&nbsp; Data collection

1.4&nbsp;&nbsp;&nbsp; Forecast parameters

1.5&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at global level

1.6&nbsp;&nbsp;&nbsp; Data validation

1.7&nbsp;&nbsp;&nbsp; Data sources

1.7.1&nbsp;&nbsp;&nbsp; Primary

1.7.2&nbsp;&nbsp;&nbsp; Secondary

1.7.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.7.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Molecular diagnostics industry 3600 synopsis, 2018 - 2032

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Product trends

2.1.3&nbsp;&nbsp;&nbsp; Technology trends

2.1.4&nbsp;&nbsp;&nbsp; Application trends

2.1.5&nbsp;&nbsp;&nbsp; End-use trends

2.1.6&nbsp;&nbsp;&nbsp; Regional trends

Chapter 3&nbsp;&nbsp;&nbsp;Molecular Diagnostics Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry landscape, 2018 &ndash; 2032

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Technological advances and increasing awareness towards early disease diagnosis globally

3.2.1.2&nbsp;&nbsp;&nbsp;Escalating demand for POC diagnostics

3.2.1.3&nbsp;&nbsp;&nbsp;Increasing geriatric population

3.2.1.4&nbsp;&nbsp;&nbsp;Increasing number of R&amp;D initiatives in developing economies

3.2.1.5&nbsp;&nbsp;&nbsp;Rising incidences of infectious diseases

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;Lack of clear and uniform regulatory framework

3.2.2.2&nbsp;&nbsp;&nbsp;Increasing cost of disease diagnostics

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By product

3.3.2&nbsp;&nbsp;&nbsp; By technology

3.3.3&nbsp;&nbsp;&nbsp; By application

3.3.4&nbsp;&nbsp;&nbsp; By end-use

3.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Regulatory Landscape

3.5.1&nbsp;&nbsp;&nbsp; U.S.

3.5.2&nbsp;&nbsp;&nbsp; Europe

3.6&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.1.1&nbsp;&nbsp;&nbsp; Bio-Rad Laboratories Inc

4.1.2&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche AG

4.1.3&nbsp;&nbsp;&nbsp; Abbott Laboratories

4.2&nbsp;&nbsp;&nbsp; Competitive dashboard, 2022

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Strategic outlook matrix

Chapter 5&nbsp;&nbsp;&nbsp;Molecular diagnostics Market, By Product

5.1&nbsp;&nbsp;&nbsp; Key segment trends

5.2&nbsp;&nbsp;&nbsp; Instruments

5.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.3&nbsp;&nbsp;&nbsp; Reagents and kits

5.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6&nbsp;&nbsp;&nbsp;Molecular Diagnostics Market, By Technology

6.1&nbsp;&nbsp;&nbsp; Key segment trends

6.2&nbsp;&nbsp;&nbsp; Polymerase chain reaction (PCR)

6.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.3&nbsp;&nbsp;&nbsp; Hybridization

6.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.4&nbsp;&nbsp;&nbsp; Sequencing

6.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.5&nbsp;&nbsp;&nbsp; Isothermal nucleic acid amplification technology (INAAT)

6.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.6&nbsp;&nbsp;&nbsp; Microarrays

6.6.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.7&nbsp;&nbsp;&nbsp; Others

6.7.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7&nbsp;&nbsp;&nbsp;Molecular Diagnostics Market, By Application

7.1&nbsp;&nbsp;&nbsp; Key segment trends

7.2&nbsp;&nbsp;&nbsp; Infectious disease diagnostics

7.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.2&nbsp;&nbsp;&nbsp; COVID-19

7.2.2.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.3&nbsp;&nbsp;&nbsp; HIV

7.2.3.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.4&nbsp;&nbsp;&nbsp; CT/NG

7.2.4.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.5&nbsp;&nbsp;&nbsp; Hepatitis B

7.2.5.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.6&nbsp;&nbsp;&nbsp; Hepatitis C

7.2.6.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.7&nbsp;&nbsp;&nbsp; RSV

7.2.7.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.8&nbsp;&nbsp;&nbsp; Flu

7.2.8.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.9&nbsp;&nbsp;&nbsp; Tuberculosis

7.2.9.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.10&nbsp;&nbsp;&nbsp; Others

7.2.10.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.3&nbsp;&nbsp;&nbsp; Oncology testing

7.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.4&nbsp;&nbsp;&nbsp; Genetic disease testing

7.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.5&nbsp;&nbsp;&nbsp; Others

7.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8&nbsp;&nbsp;&nbsp;Molecular Diagnostics Market, By End-use

8.1&nbsp;&nbsp;&nbsp; Key segment trends

8.2&nbsp;&nbsp;&nbsp; Hospitals and clinics

8.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

8.3&nbsp;&nbsp;&nbsp; Diagnostic laboratories

8.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

8.4&nbsp;&nbsp;&nbsp; Others

8.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9&nbsp;&nbsp;&nbsp;Molecular Diagnostics Market, By Region

9.1&nbsp;&nbsp;&nbsp; Key regional trends

9.2&nbsp;&nbsp;&nbsp; North America

9.2.1&nbsp;&nbsp;&nbsp; U.S.

9.2.2&nbsp;&nbsp;&nbsp; Canada

9.3&nbsp;&nbsp;&nbsp; Europe

9.3.1&nbsp;&nbsp;&nbsp; Germany

9.3.2&nbsp;&nbsp;&nbsp; UK

9.3.3&nbsp;&nbsp;&nbsp; France

9.3.4&nbsp;&nbsp;&nbsp; Spain

9.3.5&nbsp;&nbsp;&nbsp; Italy

9.3.6&nbsp;&nbsp;&nbsp; Switzerland

9.3.7&nbsp;&nbsp;&nbsp; Sweden

9.3.8&nbsp;&nbsp;&nbsp; Poland

9.4&nbsp;&nbsp;&nbsp; Asia Pacific

9.4.1&nbsp;&nbsp;&nbsp; China

9.4.2&nbsp;&nbsp;&nbsp; Japan

9.4.3&nbsp;&nbsp;&nbsp; India

9.4.4&nbsp;&nbsp;&nbsp; Australia

9.4.5&nbsp;&nbsp;&nbsp; South Korea

9.4.6&nbsp;&nbsp;&nbsp; Thailand

9.4.7&nbsp;&nbsp;&nbsp; Indonesia

9.5&nbsp;&nbsp;&nbsp; Latin America

9.5.1&nbsp;&nbsp;&nbsp; Brazil

9.5.2&nbsp;&nbsp;&nbsp; Mexico

9.5.3&nbsp;&nbsp;&nbsp; Argentina

9.5.4&nbsp;&nbsp;&nbsp; Colombia

9.5.5&nbsp;&nbsp;&nbsp; Chile

9.5.6&nbsp;&nbsp;&nbsp; Peru

9.6&nbsp;&nbsp;&nbsp; Middle East

9.6.1&nbsp;&nbsp;&nbsp; Saudi Arabia

9.6.2&nbsp;&nbsp;&nbsp; UAE

9.6.3&nbsp;&nbsp;&nbsp; Kuwait

9.6.4&nbsp;&nbsp;&nbsp; Turkey

9.6.5&nbsp;&nbsp;&nbsp; Israel

9.6.6&nbsp;&nbsp;&nbsp; Qatar

9.7&nbsp;&nbsp;&nbsp; Africa

9.7.1&nbsp;&nbsp;&nbsp; South Africa

9.7.2&nbsp;&nbsp;&nbsp; Egypt

9.7.3&nbsp;&nbsp;&nbsp; Morocco

9.7.4&nbsp;&nbsp;&nbsp; Nigeria

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles

10.1&nbsp;&nbsp;&nbsp; Abbott Laboratories

10.2&nbsp;&nbsp;&nbsp; Agilent Technologies Inc

10.3&nbsp;&nbsp;&nbsp; Becton, Dickinson and Company

10.4&nbsp;&nbsp;&nbsp; Biocartis

10.5&nbsp;&nbsp;&nbsp; Biomerieux SA

10.6&nbsp;&nbsp;&nbsp; Bio-Rad Laboratories Inc

10.7&nbsp;&nbsp;&nbsp; Danaher Corporation

10.8&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche AG

10.9&nbsp;&nbsp;&nbsp; Hologic, Inc.

10.10&nbsp;&nbsp;&nbsp; Illumina, Inc

10.11&nbsp;&nbsp;&nbsp; Qiagen

10.12&nbsp;&nbsp;&nbsp; Quidel Corporation

10.13&nbsp;&nbsp;&nbsp; Siemens Healthineers AG

10.14&nbsp;&nbsp;&nbsp; Sysmex Corporation

10.15&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific 
&nbsp;

Molecular Diagnostics Market

Inquiry Before Buying

Industries

Information

Link

Global Headquarters